BRCA2 and breast cancer: In the analytic cohort, the median age at index breast cancer diagnosis was 43 years; 40 years (range 19–72) for BRCA1, 44 (range, 27–80) for BRCA2, and 50 (range, 42–61) for PALB2. Clinical characteristics and treatment details by pathogenic variant are shown in Table 1.